OBJECTIVES: Longitudinal research indicates that cognitive load dual-task gait assessment is predictive of cognitive decline and thus might provide a sensitive measure to screen for mild cognitive impairment (MCI). However, research among older adults being clinically evaluated for cognitive concerns, a defining feature of MCI, is lacking. The present study investigated the effect of performing a cognitive task on normal walking speed in patients presenting to a memory clinic with cognitive complaints. METHODS: Sixty-one patients with a mean age of 68 years underwent comprehensive neuropsychological testing, clinical interview, and gait speed (simple- and dual-task conditions) assessments. Thirty-four of the 61 patients met criteria for MCI. RESULTS: Repeated measure analyses of covariance revealed that greater age and MCI both significantly associated with slower gait speed, ps<.05. Follow-up analysis indicated that the MCI group had significantly slower dual-task gait speed but did not differ in simple-gait speed. Multivariate linear regression across groups found that executive attention performance accounted for 27.4% of the variance in dual-task gait speed beyond relevant demographic and health risk factors. CONCLUSIONS: The present study increases the external validity of dual-task gait assessment of MCI. Differences in dual-task gait speed appears to be largely attributable to executive attention processes. These findings have clinical implications as they demonstrate expected patterns of gait-brain behavior relationships in response to a cognitive dual task within a clinically representative population. Cognitive load dual-task gait assessment may provide a cost efficient and sensitive measure to detect older adults at high risk of a dementia disorder. (JINS, 2017, 23, 493-501).
OBJECTIVES: Longitudinal research indicates that cognitive load dual-task gait assessment is predictive of cognitive decline and thus might provide a sensitive measure to screen for mild cognitive impairment (MCI). However, research among older adults being clinically evaluated for cognitive concerns, a defining feature of MCI, is lacking. The present study investigated the effect of performing a cognitive task on normal walking speed in patients presenting to a memory clinic with cognitive complaints. METHODS: Sixty-one patients with a mean age of 68 years underwent comprehensive neuropsychological testing, clinical interview, and gait speed (simple- and dual-task conditions) assessments. Thirty-four of the 61 patients met criteria for MCI. RESULTS: Repeated measure analyses of covariance revealed that greater age and MCI both significantly associated with slower gait speed, ps<.05. Follow-up analysis indicated that the MCI group had significantly slower dual-task gait speed but did not differ in simple-gait speed. Multivariate linear regression across groups found that executive attention performance accounted for 27.4% of the variance in dual-task gait speed beyond relevant demographic and health risk factors. CONCLUSIONS: The present study increases the external validity of dual-task gait assessment of MCI. Differences in dual-task gait speed appears to be largely attributable to executive attention processes. These findings have clinical implications as they demonstrate expected patterns of gait-brain behavior relationships in response to a cognitive dual task within a clinically representative population. Cognitive load dual-task gait assessment may provide a cost efficient and sensitive measure to detect older adults at high risk of a dementia disorder. (JINS, 2017, 23, 493-501).
Authors: J K Longhurst; J L Cummings; S E John; B Poston; J V Rider; A M Salazar; V R Mishra; A Ritter; J Z Caldwell; J B Miller; J W Kinney; M R Landers Journal: J Prev Alzheimers Dis Date: 2022
Authors: Kathryn L Van Pelt; Lisa Koehl; Allison Caban-Holt; Amelia Anderson-Mooney; Elizabeth Head; Frederick A Schmitt Journal: Alzheimers Dement (Amst) Date: 2020-08-25
Authors: Jason L Rucker; Joan M McDowd; Jonathan D Mahnken; Jeffrey M Burns; Carla H Sabus; Amanda J Britton-Carpenter; Nora B Utech; Patricia M Kluding Journal: PLoS One Date: 2017-10-18 Impact factor: 3.240
Authors: Hanna B Åhman; Ylva Cedervall; Lena Kilander; Vilmantas Giedraitis; Lars Berglund; Kevin J McKee; Erik Rosendahl; Martin Ingelsson; Anna Cristina Åberg Journal: BMC Geriatr Date: 2020-07-29 Impact factor: 3.921
Authors: Jason K Longhurst; Morgan A Wise; Daniel J Krist; Caitlin A Moreland; Jon A Basterrechea; Merrill R Landers Journal: J Neural Transm (Vienna) Date: 2020-04-29 Impact factor: 3.575
Authors: Hanna Bozkurt Åhman; Vilmantas Giedraitis; Ylva Cedervall; Björn Lennhed; Lars Berglund; Kevin McKee; Lena Kilander; Erik Rosendahl; Martin Ingelsson; Anna Cristina Åberg Journal: J Alzheimers Dis Date: 2019 Impact factor: 4.472
Authors: Elkin Garcia-Cifuentes; Felipe Botero-Rodríguez; Felipe Ramirez Velandia; Angela Iragorri; Isabel Marquez; Geronimo Gelvis-Ortiz; María-Fernanda Acosta; Alberto Jaramillo-Jimenez; Francisco Lopera; Carlos Alberto Cano-Gutiérrez Journal: Front Neurol Date: 2022-02-18 Impact factor: 4.003